Lataa...
Insulin detemir for the treatment of obese patients with type 2 diabetes
The risk for developing type 2 diabetes (T2DM) is greater among obese individuals. Following onset of the disease, patients with T2DM become more likely to be afflicted with diabetic micro- and macrovascular complications. Decreasing body weight has been shown to lower glycosylated hemoglobin and im...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3267521/ https://ncbi.nlm.nih.gov/pubmed/22291472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.s266980 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|